ZURA Zura Bio Ltd: institutional ownership and insider trading
111 funds reported holding $434M of Zura Bio Ltd in their latest 13F filings; in Q2 2026 funds net bought $41.5M, with 27 new positions and 22 funds selling out; over the last 12 months insiders bought $12.5M and sold $0 on the open market.
Famous investors holding ZURA
- Two Sigma (Two Sigma Investments): $2.07M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.90M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.77M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $812K, 0.0% of the portfolio
Largest institutional holders of ZURA
- SUVRETTA CAPITAL MANAGEMENT, LLC — $55.7M
- VR Adviser, LLC — $38.0M
- MPM BioImpact LLC — $26.4M
- GREAT POINT PARTNERS LLC — $24.9M
- JPMORGAN CHASE & CO (JPM, AMJB, VYLD, JPM-PC, JPM-PD, JPM-PJ, JPM-PK, JPM-PL, JPM-PM) — $24.5M
- BRAIDWELL LP — $23.5M
- Siren, L.L.C. — $22.0M
- BlackRock, Inc. (BLK) — $21.3M
- Commodore Capital LP — $19.2M
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $16.2M
Recent ZURA insider trades
- Feb 26, 2026: Blavatnik Len bought 2,000,000 shares ($12.5M)
- Nov 25, 2024: Thiara Parvinder sold 1,001,633 shares ($2.73M)
5%+ owners
- Suvretta Capital Management, LLC: 9.9% (Schedule 13G/A, filed May 12, 2026)
- Venrock Healthcare Capital Partners III, L.P.: 9.9% (Schedule 13G/A, filed May 15, 2026)